Envestnet Asset Management
SILK

Envestnet Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Envestnet Asset Management’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-48,324
Closed -$724K – 4199
2023
Q3 		$724K Buy
48,324
+12,704
+36% +$264K ﹤0.01% 3042
2023
Q2 		$1.16M Buy
35,620
+2,203
+7% +$80.4K ﹤0.01% 2639
2023
Q1 		$1.31M Sell
33,417
-979
-3% -$47.9K ﹤0.01% 2473
2022
Q4 		$1.82M Buy
34,396
+4,420
+15% +$215K ﹤0.01% 2222
2022
Q3 		$1.35M Buy
29,976
+5,909
+25% +$254K ﹤0.01% 2328
2022
Q2 		$876K Buy
24,067
+2,722
+13% +$98.9K ﹤0.01% 2703
2022
Q1 		$881K Buy
21,345
+1,487
+7% +$52.3K ﹤0.01% 2762
2021
Q4 		$846K Buy
19,858
+3,280
+20% +$164K ﹤0.01% 2735
2021
Q3 		$912K Buy
16,578
+3,772
+29% +$197K ﹤0.01% 2609
2021
Q2 		$613K Sell
12,806
-13,371
-51% -$681K ﹤0.01% 2844
2021
Q1 		$1.33M Buy
26,177
+13,344
+104% +$742K ﹤0.01% 2199
2020
Q4 		$808K Buy
12,833
+7,275
+131% +$451K ﹤0.01% 2368
2020
Q3 		$374K Sell
5,558
-851
-13% -$46.4K ﹤0.01% 2623
2020
Q2 		$268K Buy
+6,409
New +$246K ﹤0.01% 2737

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Envestnet Asset Management's SILK Position: Q4 2023 in Review

Envestnet Asset Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 48,324 shares — an estimated $724K sold.

Envestnet Asset Management first reported a position in SILK in Q2 2020 and held it in 14 quarters. The position peaked at $1.82M in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • Envestnet Asset Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 48,324 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $724K.
  • Envestnet Asset Management first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • Envestnet Asset Management's Silk Road Medical, Inc. Common Stock position peaked at $1.82M in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Envestnet Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.